A CDC advisory panel on Wednesday recommended that children as young as 12 get the Pfizer COVID-19 booster shot.
“A single Pfizer-BioNTech Covid-19 vaccine booster dose is recommended for persons aged 12 to 17 years at least 5 months after primary series under the FDA’s emergency use authorization,” the Advisory Committee on Immunization Practices said, per Just the News.
The committee voted 13 to 1 in support of the recommendation.
As previously reported by Human Events News, the FDA announced Monday that children as young as 12 may now receive the Pfizer COVID-19 booster. Booster shots were previously recommended for those over the age of 16.
“Throughout the pandemic, as the virus that causes COVID-19 has continuously evolved, the need for the FDA to quickly adapt has meant using the best available science to make informed decisions with the health and safety of the American public in mind,” Acting FDA Commissioner Janet Woodcock said in a statement.
On Tuesday, the CDC recommended that immunocompromised children between the ages of 5 and 11 get the Pfizer booster four weeks after their second shot. They also recommended shortening the time period from 6 months to 5 months after the initial vaccine series to get the booster.
The panel’s decision still needs approval from CDC Director Dr. Rochelle Walensky in order to take effect.